246 related articles for article (PubMed ID: 31106143)
1. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL).
Ghazawi FM; Alghazawi N; Le M; Netchiporouk E; Glassman SJ; Sasseville D; Litvinov IV
Front Oncol; 2019; 9():300. PubMed ID: 31106143
[TBL] [Abstract][Full Text] [Related]
2. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Roshdy O; Pehr K; Sasseville D; Litvinov IV
J Cutan Med Surg; 2018; 22(2):154-165. PubMed ID: 29241349
[TBL] [Abstract][Full Text] [Related]
3. Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.
Clough L; Bayakly AR; Ward KC; Khan MK; Chen SC; Lechowicz MJ; Flowers CR; Allen PB; Switchenko JM
Cancer; 2020 Apr; 126(8):1700-1707. PubMed ID: 31943154
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
5. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
6. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Habel Y; Risser DR; Gangar P; Jennings MA; Pehr K; Prieto VG; Sasseville D; Duvic M
Cancer; 2015 Jun; 121(12):1993-2003. PubMed ID: 25728286
[TBL] [Abstract][Full Text] [Related]
7. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.
Litvinov IV; Shtreis A; Kobayashi K; Glassman S; Tsang M; Woetmann A; Sasseville D; Ødum N; Duvic M
Oncoimmunology; 2016 Jul; 5(7):e1175799. PubMed ID: 27622024
[TBL] [Abstract][Full Text] [Related]
8. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Moreau JF; Buchanich JM; Geskin JZ; Akilov OE; Geskin LJ
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046454
[TBL] [Abstract][Full Text] [Related]
9. Clusters, crop dusters, and myth busters: a scoping review of environmental exposures and cutaneous T-cell lymphoma.
Gordon ER; Adeuyan O; Schreidah CM; Chen C; Trager MH; Lapolla BA; Fahmy LM; Weng C; Geskin LJ
Ital J Dermatol Venerol; 2023 Dec; 158(6):467-482. PubMed ID: 38015484
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
11. Update on Biology of Cutaneous T-Cell Lymphoma.
Phyo ZH; Shanbhag S; Rozati S
Front Oncol; 2020; 10():765. PubMed ID: 32477957
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
13. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Jennings MA; Risser DR; Gangar P; Netchiporouk E; Moreau L; Prieto VG; Sasseville D; Duvic M
Cancer Med; 2015 Sep; 4(9):1440-7. PubMed ID: 26136403
[TBL] [Abstract][Full Text] [Related]
14. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphoma: epidemiology, etiology, and classification.
Willemze R
Leuk Lymphoma; 2003; 44 Suppl 3():S49-54. PubMed ID: 15202525
[TBL] [Abstract][Full Text] [Related]
16. Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories.
Henry KA; Wiese D; Maiti A; Harris G; Vucetic S; Stroup AM
Cancer Causes Control; 2021 Sep; 32(9):989-999. PubMed ID: 34117957
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
18. Increased malignancy risk in the cutaneous T-cell lymphoma patient population.
Brownell I; Etzel CJ; Yang DJ; Taylor SH; Duvic M
Clin Lymphoma Myeloma; 2008 Apr; 8(2):100-5. PubMed ID: 18501103
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of primary cutaneous T-cell lymphoma in HIV-infected patients: a national population-based study.
Wang J; Liang R; Hao C; Liu X; Zhang N; Duan X; Dong H; Dong B; Gu H; Gao G; Zhang T; Bai Q; Chen X
J Investig Med; 2018 Apr; 66(4):762-767. PubMed ID: 29330308
[TBL] [Abstract][Full Text] [Related]
20. Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review.
Field H; Gao L; Motwani P; Wong HK
Dermatol Ther (Heidelb); 2016 Dec; 6(4):579-595. PubMed ID: 27590615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
